2016-08-15T00:00:00-05:00 2015-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 650N BETHESDA MD 208142930 990 2015-01-01 450672514 USAGAINSTALZHEIMER'S NETWORK USAG 2023602043 1101 K STREET NW NO 400 WASHINGTON DC 20005 GEORGE VRADENBURG PRESIDENT AND CO-FOUNDER 2023602043 2016-08-17 1 3019519090 2015 2016-12-15 16:53:06Z SALLY SACHAR 1101 K STREET NW NO 400 WASHINGTON DC 20005 6837474 0 X WWW.USAGAINSTALZHEIMERSNETWORK.ORG X 2011 DC SEE PART III, LINE 1. 7 7 5 7 0 0 4778636 6826699 0 0 -16 59 0 0 4778620 6826758 0 0 0 0 0 628965 0 0 245528 3771318 4532816 3771318 5161781 1007302 1664977 2122603 3821337 519817 553574 1602786 3267763 X USAGAINSTALZHEIMER'S NETWORK (USA2) IS AN INNOVATIVE NON-PROFIT ORGANIZATION DEMANDING - AND DELIVERING - A SOLUTION TO ALZHEIMER'S. DRIVEN BY THE SUFFERING OF MILLIONS OF FAMILIES, USAGAINSTALZHEIMER'S PRESSES FOR GREATER URGENCY FROM GOVERNMENT, (CONTINUED ON SCHEDULE O) 0 0 4424039 SINCE OUR FOUNDING USAGAINSTALZHEIMER'S NETWORK HAS WORKED ACROSS SECTORS TO ACCOMPLISH MANY MILESTONE SUCCESSES, INCLUDING:- SECURING THE NATIONAL GOAL OF PREVENTING AND EFFECTIVELY TREATING ALZHEIMER'S BY 2025 THROUGH THE NATIONAL ALZHEIMER'S PLAN.- DRAMATICALLY INCREASING GOVERNMENT INVESTMENT IN ALZHEIMER'S RESEARCH IN THE U.S. (AND PROMPTING THE U.K., CANADA AND JAPAN TO FOLLOW WITH THEIR OWN INVESTMENTS). USAGAINSTALZHEIMER'S PLAYED A KEY ROLE IN THE RECENT $360M INCREASE IN ALZHEIMER'S FUNDING APPROVED BY CONGRESS FOR FY 2016. THE INCREASE BROUGHT THE TOTAL NIH INVESTMENT TO APPROXIMATELY $936 MILLION PER YEAR, A SIGNIFICANT IMPROVEMENT IN THE PATH TOWARD OUR GOAL OF RESEARCH FUNDING EQUAL TO ONE PERCENT OF CARE COSTS, WHICH HAVE RISEN TO $226 BILLION A YEAR. THROUGH A SMART, EFFICIENT ALLOCATION OF RESOURCES, OUR RELATIVELY SMALL DIRECT INVESTMENT OF $17 MILLION (SINCE 2010) HAS HELPED GENERATE MORE THAN A CUMULATIVE $1 BILLION INCREASE IN U.S. FEDERAL ALZHEIMER'S RESEARCH FUNDING SINCE 2011 (THROUGH NIH AND THE DEPARTMENT OF DEFENSE). WE ESTIMATE THE INCREASED ALZHEIMER'S FUNDING FROM FY 2011-2016 IS SUPPORTING MORE THAN 1,000 RESEARCH GRANTS.- DRIVING GLOBAL EFFORTS THAT RESULTED IN THE LEADERS OF THE WORLD'S MOST POWERFUL NATIONS, THE G7, EMBRACING A SIMILAR 2025 GOAL AND CALLING FOR GREATER LEVELS OF INVESTMENT AND COLLABORATION. OUR CHAIRMAN, GEORGE VRADENBURG, SERVES AS A MEMBER OF THE US ADVISORY COUNCIL ON ALZHEIMER'S AND TO THE WORLD DEMENTIA COUNCIL. - RAISING PUBLIC AWARENESS THROUGH MAJOR NEWS MEDIA, INCLUDING NBC'S "TODAY" SHOW, THE NEW YORK TIMES, WALL STREET JOURNAL, USA TODAY, BLOOMBERG BUSINESS WEEK, FORBES, CHICAGO TRIBUNE, WASHINGTON POST, NEWSDAY, REUTERS, AGENCE FRANCE-PRESSE, WOMEN'S HEALTH, ROLL CALL, HUFFINGTON POST, WASHINGTON LIFE AND POLITICO.- FORGING COLLABORATIONS TO IMPROVE EFFICIENCIES FOR EXPEDITED DRUG DISCOVERY AND SPEEDING UP THE APPROVAL PROCESSES. THROUGH THE DESIGN OF A PATIENT-POWERED RESEARCH NETWORK, WHAT WE HAVE NAMED "GALAXY," WE ARE CREATING A VIRTUAL, RESEARCH-READY HUB OF CITIZEN SCIENTISTS, FAMILIES, PATIENTS AND CAREGIVERS WHOSE COLLECTIVE VOICE WILL, WE HOPE, ACCELERATE ALZHEIMER'S THERAPIES AND PREVENTIONS. WHILE WE ARE LEADING THIS WORK, WE ARE PARTNERING WITH MAYO CLINIC, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, AND THE UNIVERSITY OF FLORIDA TO EXTEND OUR EXPERTISE AND OUR CAPACITY. WE HAVE ALSO RECRUITED 37 PARTNERS TO JOIN IN A NATIONAL NETWORK TO CONNECT PATIENTS, CAREGIVERS, AND RESEARCHERS - ALL AIMED AT DEVELOPING, CONDUCTING, AND DISSEMINATING PATIENT-CENTERED DEMENTIA RESEARCH USING STATE-OF-THE-ART APPROACHES, INCLUDING MOBILE AND ONLINE TOOLS.- LAUNCHING THE GLOBAL ALZHEIMER'S PLATFORM (GAP), TO BUILD THE FIRST-EVER GLOBAL TRIAL-READY PLATFORM FOR ALZHEIMER'S DRUG DEVELOPMENT. THIS INITIATIVE WILL REDUCE THE TIME, COST AND RISK OF GETTING INNOVATIVE MEDICINES TO PERSONS WITH OR AT RISK FOR DEMENTIA. GAP HAS, TO DATE, OBTAINED FIRM COMMITMENTS OF $22.8 MILLION FROM NINE PHARMACEUTICAL COMPANIES AND TWO FOUNDATIONS TO CONTRIBUTE TO THIS PROJECT AND TO JOIN A CONSORTIUM TO HELP IN ADVANCING THIS WORK. ADDITIONALLY, WE ARE CONDUCTING ONGOING FUNDRAISING CONVERSATIONS WITH SEVERAL OTHER POTENTIAL FUNDERS, INCLUDING MAJOR HEALTH INSURERS, FOUNDATIONS, AND INTERNATIONAL ORGANIZATIONS. WE ARE ALSO SEEKING $25 MILLION IN FUNDING FROM THE NATIONAL INSTITUTES OF HEALTH AS WELL AS THEIR AGREEMENT TO JOIN WHAT WOULD BE A PUBLIC-PRIVATE CONSORTIUM TO EXECUTE THIS PROJECT. IN TOTAL, WE ARE SEEKING $70 MILLION IN FUNDING OVER THE FIVE-YEAR PERIOD IT WILL TAKE TO BUILD THIS PLATFORM.- USING BIG DATA TO SPEED PROGRESS TOWARD A CURE. USAGAINSTALZHEIMER'S INDUSTRY COALITION - CALLED THE GLOBAL CEO INITIATIVE ON ALZHEIMER'S DISEASE (CEOI) - LAUNCHED THE "BIG DATA RESEARCH INITIATIVE TO FIGHT ALZHEIMER'S DISEASE," TARGETED AT DRAWING TOGETHER STAKEHOLDERS FROM INDUSTRY, ACADEMIA AND GOVERNMENT AGENCIES TO ACCELERATE THE PACE OF ALZHEIMER'S RESEARCH FOR TREATMENTS AND CARE. IN THIS EFFORT, WE ARE PARTNERING WITH THE LARGE HEALTH INSURER OPTUM, ITS RESEARCH ARM OPTUMLABS, AND WITH J&J, BIOGEN, ASTRAZENECA, AND MAYO CLINIC, AMONG OTHERS.- CO-CONVENING LEADERS ENGAGED ON ALZHEIMER'S DISEASE (LEAD), A NATIONWIDE, GRASSROOTS COALITION OF MORE THAN 70 ORGANIZATIONS/CORPORATIONS AND 170,000 INDIVIDUALS. OUR CO-CONVENING PARTNER IN THIS EFFORT IS VOLUNTEERS OF AMERICA.- PROVIDING CURRENT, CONTENT-RICH, ACCESSIBLE INFORMATION TO A WIDE ARRAY OF AUDIENCES IN A NUMBER OF FORMATS. WE HAVE VASTLY INCREASED ACCESS TO INFORMATION ABOUT ALZHEIMER'S DISEASE TO DIVERSE AUDIENCES SUCH AS PATIENTS, FAMILIES, INDUSTRY LEADERS, FAITH COMMUNITIES, RESEARCHERS, PROVIDERS, PAYERS, ELECTED OFFICIALS AND MORE. THIS IS DONE THROUGH A NUMBER OF FORMATS AND MEDIUM, INCLUDING OUR ALZDAILY, EMAIL UPDATES, ALZTALKS WEBINARS, RESEARCH AND PIPELINE REPORTS, EDITORIALS, AND MORE.- MOBILIZING NETWORKS IN DISPROPORTIONATELY IMPACTED COMMUNITIES. USAGAINSTALZHEIMER'S IS COMMITTED TO ENGAGING AND MOBILIZING THOSE WHO HAVE BEEN IMPACTED BY ALZHEIMER'S DISEASE. OUR NETWORKS INCLUDE: WOMENAGAINSTALZHEIMER'S, AFRICANAMERICANSAGAINSTALZHEIMER'S, LATINOSAGAINSTALZHEIMER'S, CLERGYAGAINSTALZHEIMER'S, AND RESEARCHERSAGAINSTALZHEIMER'S. EACH NETWORK ENGAGES IN A PROGRAM OF EVENTS AND ACTIONS THAT FIT THEIR UNIQUE NEEDS.- BEING A VOICE AND SOURCE OF SUPPORT FOR THOSE LIVING WITH ALZHEIMER'S DISEASE. USAGAINSTALZHEIMER'S HAS A NUMBER OF PROGRAMS TO POSITIVELY IMPACT THE LIVES OF THOSE LIVING WITH ALZHEIMER'S DISEASE. THIS INCLUDES OUR SEASONS OF CARING: MEDITATIONS FOR ALZHEIMER'S AND DEMENTIA CAREGIVERS, DIRECT WORK WITH ADVOCATES AND CAREGIVERS TO SPEAK WITH THEIR ELECTED OFFICIALS, AND PROVIDE A PLATFORM FOR SHARING THEIR STORIES. 4424039 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 50 0 1 5 1 0 0 0 0 0 0 0 0 0 0 X 7 7 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AR CA CO CT FL GA HI IL KS KY ME MD MA MI MN MS NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X SALLY SACHAR 2023493803 1101 K STREET NW SUITE 400 WASHINGTON DC 20005 X GEORGE VRADENBURG PRESIDENT & CO-FOUNDER 40.00 X X 0 0 0 PATRICIA VRADENBURG VICE PRESIDENT & CO-FOUNDER 5.00 X X 0 0 0 JILL LESSER SECRETARY 5.00 X X 0 0 0 SHAWN TAYLOR TREASURER 5.00 X X 0 0 0 MERYL COMER BOARD MEMBER 1.00 X 0 0 0 PETER LEVIN BOARD MEMBER 1.00 X 0 0 0 STANLEY PRUSINER BOARD MEMBER 1.00 X 0 0 0 SALLY SACHAR SEE SCH L O CHIEF OPERATING OFFICER 40.00 X 162509 0 0 KATHLEEN GREALISH CHIEF DEVELOPMENT OFFICER 32.00 X 146667 0 0 VIRGINIA BIGGAR DIRECTOR, CLERGY/ACTIVIST 30.00 X 109921 0 0 ELIZABETH PLANT DIRECTOR, ALZ TALKS 40.00 X 109921 0 0 529018 0 0 4 0 1 0 FAEGRE BAKER DANIELS LLP 1050 K STREET NW SUITE 400 WASHINGTON DC 20007 FEDERAL POLICY/AWARENESS 533880 HIGH LANTERN GROUP 630 THIRD AVE 22ND FLOOR NEW YORK NY 10017 PROGRAM STRAT/MGMT 480742 ANNE LEWIS STRATEGIES LLC 1140 19TH STREET NW SUITE 300 WASHINGTON DC 20036 COMMUNICATIONS AND MEDIA 317445 LINDER & ASSOCIATES 2150 WISCONSIN AVENUE NW WASHINGTON DC 20007 EVENT COORDINATOR 282980 IAN N KREMER 2920 PARKLAWN CT HERNDON VA 20171 PROGRAM STRAT/MGMT 177563 9 6826699 8684 6826699 10775 10716 59 59 59 6826758 0 0 59 X 130008 102706 13001 14301 453324 352191 4018 97115 45633 9583 1369 34681 86094 37699 48395 13008 13008 3956952 3529619 339685 87648 61092 61092 34485 2117 32368 70067 68987 1080 19262 19262 220200 218878 1322 44089 41167 2922 14237 14237 STATE REGISTRATION FEES 11783 11783 PAYROLL FEES 1547 1547 5161781 4424039 492214 245528 2069371 3603746 51200 207481 2032 0 10110 2122603 3821337 479817 552939 40000 635 519817 553574 X 1115 157946 1601671 3109817 1602786 3267763 2122603 3821337 1664977 0 X 0 1 X 1 0 X 769759 1977755 2930557 4778636 6826699 17283406 769759 1977755 2930557 4778636 6826699 17283406 6396232 10887174 17283406 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE TO USAGAINSTALZHEIMER'S 635 635 X 6828858 2100 2100 6826758 0 6826758 5163881 2100 2100 5161781 0 5161781 PART X, LINE 2: FOR THE YEAR ENDED DECEMBER 31, 2015, USAA HAS DOCUMENTED THEIR CONSIDERATION OF FASB ASC 740-10, INCOME TAXES, THAT PROVIDES GUIDANCE FOR REPORTING UNCERTAINTY IN INCOME TAXES AND HAS DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE COMBINED FINANCIAL STATEMENTS. X X 0 0 0 0 0 0 0 0 0 SALLY SACHAR SEE SCH L O CHIEF OPERATING OFFICER 162509 0 0 0 0 0 0 0 0 0 162509 0 0 0 PRACTICAL STRATEGY LLC SALLY SACHAR, COO OF USAAN, WAS ALSO THE OWNER OF PRACTICAL STRATEGY LLC. 109161 USAGAINSTALZHEIMER'S NETWORK CONTRACTS WITH PRACTICAL STRATEGY LLC. TO PROVIDE PROGRAM STRATEGY, AND ADMINISTRATIVE SERVICES TO THE USAGAINSTALZHEIMER'S NETWORK. 0 CHANGING OUR WORLD INC CHANGING OUR WORLD, INC. IS A SUBSTANTIAL CONTRIBUTOR OF USAAN. 100456 USAGAINST ALZHEIMER'S NETWORK CONTRACTED CHANGING OUR WORLD, INC. FOR DEVELOPMENT WORK. PER 990 INSTRUCTIONS, CHANGING OUR WORLD, INC. IS A SUBSTANTIAL CONTRIBUTOR AND, THEREFORE, AN INTERESTED PERSON FOR SCHEDULE L PURPOSES. 0 FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: INDUSTRY AND THE SCIENTIFIC COMMUNITY IN THE QUEST FOR AN ALZHEIMER'S CURE - ACCOMPLISHING THIS THROUGH EFFECTIVE LEADERSHIP, COLLABORATIVE ADVOCACY, AND STRATEGIC INVESTMENTS. FOUNDED IN 2011, USAGAINSTALZHEIMER'S NETWORK HAS WORKED ACROSS SECTORS TO: (1) SECURE THE NATIONAL GOAL OF PREVENTING AND EFFECTIVELY TREATING ALZHEIMER'S BY 2025 AND HELP SECURE NEARLY $500 MILLION IN ADDITIONAL PUBLIC FUNDING FOR ALZHEIMER'S RESEARCH OVER THE PAST FEW YEARS; (2) DRIVE GLOBAL EFFORTS THAT RESULTED IN THE LEADERS OF THE WORLD'S MOST POWERFUL NATIONS, THE G7 GROUP, TO EMBRACE A SIMILAR 2025 GOAL AND TO CALL FOR GREATER LEVELS OF RESEARCH INVESTMENT AND COLLABORATION; AND (3) FORGE INDUSTRY COMMITMENTS TO IMPROVE EFFICIENCIES FOR AN EXPEDITED DRUG DISCOVERY AND APPROVAL PROCESS. USAGAINSTALZHEIMER'S THEORY OF CHANGE IS ROOTED IN THE STRONG BELIEF THAT WE, THE AMERICAN PEOPLE, CAN CREATE THE NATIONAL WILL TO PREVENT AND TREAT ALZHEIMER'S BY PRESSURING OUR POLITICAL, BUSINESS AND CIVIC LEADERS TO DEVOTE THE NECESSARY RESOURCES TO OUTCOMES-ORIENTED RESEARCH AND TO REFORM THE DRUG DEVELOPMENT SYSTEMS THAT CURRENTLY SLOW THE DEVELOPMENT AND AVAILABILITY OF PROMISING TREATMENTS. WE CALL THIS "LEADERSHIP FOR THE CURE. AND IT WORKS. FORM 990, PART VI, SECTION A, LINE 2 GEORGE AND PATRICIA VRADENBURG HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED BY ONE OF THE DIRECTORS AND THE CHIEF OPERATING OFFICER. A COPY OF THE FORM 990 WAS PROVIDED TO THE ORGANIZATION'S GOVERNING BODY BEFORE IT WAS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS ANNUALLY SIGNS A STATEMENT WHICH AFFIRMS THAT EACH HE/SHE: A. HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY, B. HAS READ AND UNDERSTANDS THE POLICY, C. HAS AGREED TO COMPLY WITH THE POLICY, AND D. UNDERSTANDS THAT THE ORGANIZATION IS A NON-PROFIT PUBLIC BENEFIT CORPORATION AND, IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION, IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE LEAVES THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS DECIDE IF A CONFLICT OF INTEREST EXISTS. FORM 990, PART VI, SECTION B, LINE 15A IN PRIOR YEARS, SALLY SACHAR PROVIDED SERVICES AS COO THROUGH PRACTICAL STRATEGY, LLC, AN INDEPENDENT CONTRACTOR. AT THE BEGINNING OF THE YEAR, SHE BECAME A FULL-TIME EMPLOYEE. THE COMPENSATION FOR THE COO WAS DETERMINED BY THE BOARD USING COMPARABILITY DATA. THE BOARD REVIEWS THE COMPENSATION AT ITS QUARTERLY MEETINGS AND DOCUMENTS THE DECISIONS IN THE ORGANIZATION'S BOARD MINUTES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART VII, LINE 1 USAGAINSTALZHEIMER'S NETWORK (USAAN) AND USAGAINSTALZHEIMER'S (USAA) HAVE ENTERED INTO A COST-SHARING ARRANGEMENT UNDER WHICH USAA REIMBURSES USAAN FOR USAA'S ALLOCABLE SHARE OF THE COMPENSATION OF CERTAIN EMPLOYEES FOR SERVICES PROVIDED TO USAA. COMPENSATION REIMBURSED BY USAA IS NOT ADDITIVE TO THE COMPENSATION REPORTED FOR THESE SHARED EMPLOYEES BY USAAN. USAAN AND USAA ARE NOT "RELATED ORGANIZATIONS" AS THAT TERM IS DEFINED IN THE FORM 990 GLOSSARY. PURSUANT TO THEIR AGREEMENT, USAA REIMBURSED USAAN FOR ITS SHARE OF COMPENSATION AS FOLLOWS: SALLY SACHER (OFFICER) $32,501 FORM 990, PART IX, LINE 11G FINANCIAL MANAGEMENT: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 158,326. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 158,326. FED RELATION & POLICY AWARENESS: PROGRAM SERVICE EXPENSES 487,823. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 487,823. SPECIAL PROJECT - RESEARCH: PROGRAM SERVICE EXPENSES 23,609. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 5,500. TOTAL EXPENSES 29,109. MEDIA/COMMUNICATIONS CONSULTANTS: PROGRAM SERVICE EXPENSES 690,334. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 690,334. LEAD DUES: PROGRAM SERVICE EXPENSES 25,000. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 25,000. IN-HOUSE DEVELOPMENT: PROGRAM SERVICE EXPENSES 197,644. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 64,320. TOTAL EXPENSES 261,964. EVENT FIRM: PROGRAM SERVICE EXPENSES 221,058. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 13,270. TOTAL EXPENSES 234,328. LONG TERM CARE COMMISSION: PROGRAM SERVICE EXPENSES 50,000. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 50,000. ALLIANCES: PROGRAM SERVICE EXPENSES 11,893. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 11,893. PCORI CONTRACTORS: PROGRAM SERVICE EXPENSES 70,825. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 70,825. WA2 EVENTS CONTRACTORS: PROGRAM SERVICE EXPENSES 189,910. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 189,910. NGG CONTRACTORS: PROGRAM SERVICE EXPENSES 23,286. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 23,286. SURVIVING GRACE CONSULTANTS: PROGRAM SERVICE EXPENSES 80,267. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 80,267. OTHER CONSULTANTS: PROGRAM SERVICE EXPENSES 140,293. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 4,558. TOTAL EXPENSES 144,851. PROGRAM MANAGEMENT/STRATEGY: PROGRAM SERVICE EXPENSES 1,069,799. MANAGEMENT AND GENERAL EXPENSES 181,359. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,251,158. PROGRAM PROJECT FUNDRAISING CONSULTANTS: PROGRAM SERVICE EXPENSES 148,337. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 148,337. REGISTRIES TO COHORT: PROGRAM SERVICE EXPENSES 99,541. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 99,541. FORM 990, PART IX, LINE 11G: FOR MANY CAPACITIES, USA2/N CONTRACTS WITH FIRMS TO PROVIDE CORE CAPACITIES, INCLUDING POLICY/LEGISLATIVE AFFAIRS, COMMUNICATIONS AND MEDIA, DIGITAL MARKETING, AND TO LEAD TWO OF OUR CORE NETWORKS (RESEARCHERSAGAINSTALZHEIMER'S AND WOMENAGAINSTALZHEIMER'S).